Significance of appropriate defibrillator shock 3 hours and 20 minutes following implantation in a patient with hypertrophic cardiomyopathy

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 3, 2008, Pages 319-322

  Almquist, Adrian K ^a   Hanna, Constance A ^a   Haas, Tammy S ^a   Maron, Barry J ^a,b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b Hypertrophic Cardiomyopathy Center   (United States)

Author keywords

Cardiomyopathy; Defibrillator; Ventricular fibrillation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MAGNESIUM; MYOSIN BINDING PROTEIN C; POTASSIUM; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE; CASE REPORT; DEFIBRILLATOR; DEVICE; ELECTROCARDIOGRAPHY; ELECTROLYTE BLOOD LEVEL; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SUDDEN DEAFNESS;

CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSTHESIS IMPLANTATION; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 39749123234     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.00942.x     Document Type: Article

References (12)

1. Maron BJ, Shen W-K, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NAM III., Casey SA, Stanton MS, Betocchi S, Spirito P : Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000 342 : 365 373.
2. Maron BJ, Spirito P, Shen W-K, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NAM III., Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P : Implantable cardioverter - defibrillators and prevention of sudden cardiac death and selection of patients for implantable cardioverter-defibrillators in hypertrophic cardiomyopathy. JAMA 2007 298 : 405 412.
3. Jayatilleke I, Doolan A, Ingles J, McGuire M, Booth V, Richmond DR, Semsarian C : Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy. Am J Cardiol 2004 : 93 : 1192 1194.
4. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, ten Cate FJ, Wigle ED : American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003 42 : 1687 1713.
5. Maron BJ : Hypertrophic cardiomyopathy: A systematic review. JAMA 2002 287 : 1308 1320.
6. Germano JJ, Reynolds M, Essebag V, Josephson ME : Frequency and causes of implantable cardioverter-defibrillator therapies: Is device therapy proarrhythmic? Am J Cardiol 2006 97 : 1255 1261.
7. Böcker D, Block M, Isbruch F, Weitholt D, Hammel D, Scheld HH, Borgreffe M, Breithardt G : Comparison of frequency of aggravation of ventricular tachyarrhythmias after implantation of automatic defibrillators using epicardial versus nonthoracotomy lead systems. Am J Cardiol 1993 71 : 1064 1068.
8. Maron BJ, Estes NAM III., Maron MS, Almquist AK, Link MS, Udelson J : Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 2003 107 : 2872 2875.
9. Almquist AK, Montgomery JV, Haas TS, Maron BJ : Cardioverter- defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm 2005 2 : 814 819.
10. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ : Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005 45 : 697 704.
11. Maron BJ, Roberts WC : Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 1979 59 : 689 706.
12. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TDT, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D : Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy. Single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004 109 : 1503 1508.